Article Text

Download PDFPDF

Education and treatment adherence during the COVID-19 pandemic. Response to: ‘Adherence to medication in patients with rheumatic diseases during COVID-19 pandemic’ by Khabbazi et al
Free
  1. Rita Angélica Pineda-Sic1,
  2. Griselda Serna-Peña1,
  3. Jesus Alberto Cardenas-de la Garza1,
  4. Sergio A Torres-Castillo2,
  5. Dionicio Angel Galarza-Delgado1,
  6. Diana Elsa Flores-Alvarado1
  1. 1Rheumatology, Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo Leon, Mexico
  2. 2Servicio de Neurología, Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo Leon, Mexico
  1. Correspondence to Dr Dionicio Angel Galarza-Delgado, Rheumatology, Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo Leon, PC 64460, Mexico; dgalarza{at}medicinauanl.mx

Statistics from Altmetric.com

With great interest, we read the study of Dr Khabbazi et al1 regarding treatment adherence in patients with inflammatory rheumatic diseases during the COVID-19 pandemic in the East Azarbaijan province of Iran. They conducted telephone interviews to 1324 patients and inquired about treatment adherence behaviours during 2 weeks from July 2020. Of the 858 patients included in the final analysis, non-adherence was reported by 6.5% of the patients (defined by the group as ≥20% change in the dose or frequency of medications). In accordance to previous studies,2 …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles